NeuroOne Medical Technologies Corporation (NASDAQ:NMTC - Get Free Report) insider David Wambeke purchased 1,000,000 shares of the firm's stock in a transaction that occurred on Sunday, March 1st. The...
NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting severe facial pain, scheduled to launch in late 2025.